| Rank |
Status |
Study |
| 1 |
Recruiting
|
Intrapleural Minocycline After Simple Aspiration for the Prevention of Primary Spontaneous Pneumothorax
| Condition: |
Pneumothorax |
| Interventions: |
Procedure: Simple Aspiration with minocycline pleurodesis; Procedure: simple Aspiration |
| Outcome Measures: |
to compare the rates of ipsilateral recurrence between the minocycline and observation groups after simple Aspiration of the pneumothorax.; Safety profile of minocycline pleurodesis; Early results, including immediate success rates, one-week success rates, complication rates, rates of hospitalization, duration of hospitalization, and the degrees of chest pain.; Long-term effects of minocycline pleurodesis, including degrees of residual chest pain and pulmonary function test |
|
| 2 |
Unknown †
|
Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab
| Conditions: |
Myocardial Infarction; Occlusive Thrombus |
| Interventions: |
Other: Intracoronary direct injection; Other: Intracoronary and distal injection by Aspiration device; Other: Intracoronary distal injection by Aspiration catheter device |
| Outcome Measures: |
Infarct size; Major Adverse Cardiac and Cerebrovascular Events (MACCE) |
|
| 3 |
Recruiting
|
Physiologic Assessment of Thrombus Aspiration in Acute ST-segment Elevation Myocardial Infarction Patients
| Condition: |
Myocardial Infarction |
| Interventions: |
Device: Eliminate Aspiration catheter; Procedure: Conventional primary angioplasty |
| Outcome Measures: |
IMR (mmHg seconds) in thrombus Aspiration compared to conventional PCI group; Resolution of ST-segment elevation; myocardial blush grade (0-3); infarct size assessed by peak enzyme release (Troponin, creatine kinase MB (CK-MB)); indices of left ventricle remodeling on Echocardiography; infarct size determined by SPECT |
|
| 4 |
Recruiting
|
Aspiration of Residual Gastric Contents
| Conditions: |
Infant, Premature; Nutrition, Enteral |
| Interventions: |
Procedure: No Aspiration of gastric contents; Procedure: Routine Aspiration of gastric contents |
| Outcome Measures: |
24-hour enteral feeding intake in mL/kg; Time to reach full feeds; Hours receiving parenteral nutrition; Weekly or biweekly liver function tests; Hours of central venous line access; Episodes of late onset sepsis; Growth indices; Length of hospital stay; Episodes of necrotizing enterocolitis; Presence of blood in stools; Level of fecal calprotectin; serum gastrin level; motilin level; tracheal pepsin levels; presence of Aspiration pneumonia; presence of ventilator associated pneumonia |
|
| 5 |
Recruiting
|
Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET
| Condition: |
Infertility |
| Interventions: |
Procedure: Needle Aspiration of hydrosalpinx; Procedure: Salpingectomy |
| Outcome Measures: |
The Number of Participants Who Achieved Clinical Pregnancy in a Transfer Cycle; The Number of Participants Who Achieved Ongoing Pregnancy in a Transfer Cycle . |
|
| 6 |
Recruiting
|
Virtual Bronchoscopy (VB) vs. Endobronchial Ultrasound (EBUS) Guided Mediastinal Sampling
| Conditions: |
Lung Cancer,; Mediastinal Tumors,; Lymphomas,; Sarcoidosis, |
| Interventions: |
Procedure: virtual bronchoscopy guided transbronchial needle Aspiration; Procedure: endobronchial ultrasound guided transbronchial needle Aspiration |
| Outcome Measures: |
Adequacy of cytologic specimens collected by VB-TBNA vs. EBUS-TBNA; Diagnostic accuracy of VB-TBNA vs. EBUS-TBNA - the number (and percentage) of cytologic specimens containing diagnostic material (neoplastic cells, granulomas) |
|
| 7 |
Recruiting
|
Comparison of Gastric Bypass and AspireAssist Aspiration Therapy for Treatment of Morbid Obesity
| Condition: |
Obesity |
| Interventions: |
Procedure: Gastric Bypass; Device: AspireAssist Aspiration Therapy |
| Outcome Measures: |
Weight Loss; Quality of Life |
|
| 8 |
Recruiting
|
Sellick Interest in Rapid Sequence Induction
| Conditions: |
Rapid Sequence Induction of General Anesthesia; Sellick Maneuver; Acid Aspiration Syndrome; Lung Aspiration; Aspiration Pneumonia |
| Interventions: |
Other: effective sellick maneuver; Other: sham sellick maneuver |
| Outcome Measures: |
Incidence of lung Aspiration; Cormack and Lehane Grade; Frequency of use of a mask ventilation; Number of times the Sellick maneuver should be discontinued; Effects of releasing the Sellick maneuver on the conditions of tracheal intubation assessed by Cormack and Lehane grade; Incidence of difficult and impossible intubation; Incidence of Aspiration pneumonia; Incidence of oesophageal rupture; Incidence of cricoid cartilage fracture; Mortality |
|
| 9 |
Unknown †
|
Aspiration Device in Myocardial Infarction Trial
| Condition: |
Angioplasty |
| Intervention: |
Device: repeated thrombus Aspiration during primary PCI |
| Outcome Measures: |
Limitation of infarct size; Early and follow up related (MACE)-major adverse cardiac events; Efficacy of using Aspiration device after every stage of Primary angiplasty |
|
| 10 |
Recruiting
|
Trial of Endobronchial Ultrasound Guided Fine Needle Aspiration Techniques
| Condition: |
Lung Cancer |
| Intervention: |
Device: EBUS guided FNA with and without suction |
| Outcome Measures: |
Sensitivity of each needle Aspiration technique for diagnosis of malignancy; Diagnostic accuracy of each needle Aspiration technique for diagnosis of malignancy; Adequacy of the needle Aspiration sample; Negative predicted value of each needle Aspiration technique for diagnosis of malignancy; Specificity of each needle Aspiration technique for diagnosis of malignancy; Positive predicted value of each needle Aspiration technique for diagnosis of malignancy |
|
| 11 |
Unknown †
|
Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study
| Condition: |
Non-ST-Elevation Myocardial Infarction |
| Interventions: |
Procedure: Thrombus Aspiration followed by stent implantation; Procedure: conventional PCI |
| Outcome Measures: |
Incidence of myocardial blush grade 3 after PCI; Coronary angiographic outcomes; Histopathological outcomes of atherothrombotic material; Enzymatic infarct size; Electrocardiographic outcomes; Clinical outcomes at 30 days and 1 year |
|
| 12 |
Recruiting
|
Efficacy of Combining Pasireotide With Aspiration Ssclerotherapy to Improve Volume Reduction of Hepatic Cysts
| Condition: |
Symptomatic Dominant Liver Cyst |
| Interventions: |
Drug: Pasireotide LAR 60 mg; Procedure: Aspiration sclerotherapy; Drug: Placebo |
| Outcome Measures: |
Proportional diameter change; Absolute reduction (cm) hepatic cyst; Proportional (%) and absolute cyst reduction (cm) after 12 weeks; Proportion cyst recurrence; Symptomatic change and health-related quality of life; Safety |
|
| 13 |
Unknown †
|
Comparison Of Surfactant Lung Lavage With Standard Care In The Treatment Of Meconium Aspiration Syndrome
| Condition: |
Meconium Aspiration Syndrome |
| Intervention: |
Drug: Bovine surfactant |
| Outcome Measures: |
duration of oxygen therapy in hours; Severity of respiratory distress; need for mechanical ventilation; Duration of mechanical ventilation; Complications; Incidence of sepsis; Mortality; Duration of Hospital stay |
|
| 14 |
Unknown †
|
Trial of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Nasopharyngeal Aspiration
| Condition: |
Pain |
| Interventions: |
Drug: 88% sucrose po; Drug: placebo po |
| Outcome Measures: |
Difference in pains scores related to nasopharyngeal Aspiration; Difference in pain scores related to nasopharyngeal Aspiration |
|
| 15 |
Unknown †
|
Modified Stereotactic Aspiration and Thrombolysis of Intracerebral Hemorrhage:a Multi-center Controlled Study
| Condition: |
Hypertensive Intracerebral Hemorrhage |
| Interventions: |
Device: Stereotactic Aspiration and Thrombolysis; Drug: conservative treatment |
| Outcome Measures: |
The rate of rebleeding and mortality, Glasgow Outcome Scale for prognosis; Nation of Health Stroke Scale Score , modified Rankin Scale, Barthel Index complications |
|
| 16 |
Recruiting
|
Suprapubic Aspiration Versus Urinary Catheterization In Neonates.
| Condition: |
Neonatal Urinary Tract Infection |
| Interventions: |
Procedure: Suprapubic Aspiration; Procedure: Urinary Catheterization |
| Outcome Measures: |
Number of contaminated urine samples per SPA and UC; Success rates of obtaining urine by SPA versus UC; Time to perform the respective procedures; Complication rates of SPA versus UC; Contamination rates of SPA versus UC (excluding clean catch urine); Number of attempts per procedure |
|
| 17 |
Unknown †
|
Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium Aspiration
| Condition: |
Meconium Aspiration Syndrome |
| Interventions: |
Drug: Bovine Lipid Extract Surfactant (administered by lavage); Drug: Bovine Lipid Extract Surfactant (administered by bolus) |
| Outcome Measures: |
% change in oxygenation indices from baseline to 1 and 6 h following treatment; % change in dynamic pulmonary compliance from baseline to 1 and 6 h following treatment; % change in pulmonary artery pressure from baseline to 1 and 6 h following treatment; measures of efficacy of ventilation and oxygenation at 1 h and 6 h following treatment; cardiac function by echocardiography at 6 hours following treatment; % change in oxygenation indices, dynamic pulmonary compliance and pulmonary vascular resistance from baseline to 12, 24 and 48 h following treatment; measures of efficiency of ventilation and oxygenation at 12, 24 and 48 h following treatment; duration of mechanical ventilation, defined as the cumulative time of mechanical ventilation; length of time on CPAP; length of time with oxygen supplementation; length of time on inotropes and maximum inotropic score.; need for and length of use of NO; need for and length of use of ECMO; time to full enteral feeds; attainment of exit criteria; development of significant pulmonary hemorrhage; development of significant intracranial hemorrhage; development of tension pneumothorax requiring drainage; need for repeat surfactant; length of stay in a level III NICU; mortality |
|
| 18 |
Unknown †
|
Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy
| Conditions: |
Brain and Central Nervous System Tumors; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Pain; Precancerous Condition; Unspecified Adult Solid Tumor, Protocol Specific |
| Interventions: |
Other: questionnaire administration; Procedure: acupressure therapy; Procedure: biopsy; Procedure: bone marrow Aspiration; Procedure: pain therapy |
| Outcome Measures: |
Pain scores before and during bone marrow Aspiration and biopsy (BMAB) as measured by a patient-reported 11-point visual analogue pain scale; Clinical benefit response as measured by duration of BMAB, patient's rating of the procedure, and patient's willingness to receive acupressure during subsequent BMAB |
|
| 19 |
Not yet recruiting
|
Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic Cancer
| Condition: |
Pancreatic Cancer |
| Interventions: |
Device: 22 gauge ProCore needle Aspiration; Device: 22 gauge Fine needle Aspiration |
| Outcome Measures: |
The rates of diagnostic sufficiency; The presence of histologic core |
|
| 20 |
Unknown †
|
Effects of Tracheal Tube Size on Pulmonary Aspiration
| Condition: |
The Reduction of Aspiration Rate in Intubated Patients |
| Intervention: |
Other: Observation of fluid leakage around tracheal tube cuffs |
| Outcome Measure: |
Aspiration rate |
|
